[Clinical research in general hospital centres in France, strengths and weaknesses].

Recherche clinique au sein des centres hospitaliers généraux en France, forces et faiblesses.
Centre hospitalier général Clinical research General hospital Recherche clinique

Journal

Cancer radiotherapie : journal de la Societe francaise de radiotherapie oncologique
ISSN: 1769-6658
Titre abrégé: Cancer Radiother
Pays: France
ID NLM: 9711272

Informations de publication

Date de publication:
Sep 2023
Historique:
received: 16 06 2023
revised: 07 07 2023
accepted: 10 07 2023
medline: 12 9 2023
pubmed: 13 8 2023
entrez: 12 8 2023
Statut: ppublish

Résumé

Clinical research is an essential activity in cancer care. Both for patients, who can gain access to innovative therapies, and for practitioners, who can maintain their skills and stay at the forefront of new treatment approaches. First developed in university hospitals, clinical research is now established in general hospitals and private health institutions. The number of patient inclusions in clinical trials has doubled over the last ten years, thus reflecting the dynamism of it. Strengths and weaknesses, opportunities and threats concerning clinical research, and more specifically clinical research in general hospitals, are exposed in this article.

Identifiants

pubmed: 37573194
pii: S1278-3218(23)00150-6
doi: 10.1016/j.canrad.2023.07.008
pii:
doi:

Types de publication

English Abstract Journal Article

Langues

fre

Sous-ensembles de citation

IM

Pagination

460-463

Informations de copyright

Copyright © 2023 Société française de radiothérapie oncologique (SFRO). Published by Elsevier Masson SAS. All rights reserved.

Auteurs

D Argo-Leignel (D)

Groupe hospitalier Bretagne Sud, 5, avenue de Choiseul, 56520 Lorient, France. Electronic address: d.argoleignel@ghbs.bzh.

P Bouju (P)

Groupe hospitalier Bretagne Sud, 5, avenue de Choiseul, 56520 Lorient, France.

M Le Saux (M)

Groupe hospitalier Bretagne Sud, 5, avenue de Choiseul, 56520 Lorient, France.

N Leissen (N)

Groupe hospitalier Bretagne Sud, 5, avenue de Choiseul, 56520 Lorient, France.

R Guégan (R)

Groupe hospitalier Bretagne Sud, 5, avenue de Choiseul, 56520 Lorient, France.

Y Pointreau (Y)

Institut inter-régional de cancérologie (ILC), centre Jean-Bernard, 64, rue de Degré, 72000 Le Mans, France.

Y Alexandre (Y)

Groupe hospitalier Bretagne Sud, 5, avenue de Choiseul, 56520 Lorient, France.

G Bera (G)

Groupe hospitalier Bretagne Sud, 5, avenue de Choiseul, 56520 Lorient, France.

Articles similaires

[Redispensing of expensive oral anticancer medicines: a practical application].

Lisanne N van Merendonk, Kübra Akgöl, Bastiaan Nuijen
1.00
Humans Antineoplastic Agents Administration, Oral Drug Costs Counterfeit Drugs

Smoking Cessation and Incident Cardiovascular Disease.

Jun Hwan Cho, Seung Yong Shin, Hoseob Kim et al.
1.00
Humans Male Smoking Cessation Cardiovascular Diseases Female
Humans United States Aged Cross-Sectional Studies Medicare Part C
1.00
Humans Yoga Low Back Pain Female Male

Classifications MeSH